瑞銀:維持中國平安(2318.HK)“買入”評級 目標價107港元
瑞銀髮表報告指,中國平安(2318.HK)
將於2月20日公佈去年業績,預期集團去年第四季的新業務價值增長4.5%,與其指引相若。而平安為首間公佈業績的中資險商,該行預期集團將面對投資者問及新型肺炎疫情造成的影響,但相信集團在新業務銷售面對的影響會較索賠為大。瑞銀將中國平安股份目標價由108港元微降至107港元,評級維持“
買入
”。
另外,又下調集團今年新業務價值增長預測,由原來預期增長12%降至8%。不過因保險意識提高和代理改革成效,明年新業務價值增長料將加快至15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.